RxDoctor Payments Data

Join Luh, MD

Radiation Oncology · Eureka, CANPI 1093809634

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by EMD Serono, Inc. at 43.0% of the total. Reporting peaked in 2023 at $5,378 and has fallen 52.6% since, to $2,549 in 2025. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,315in general payments, 2019–2025

Across 47 payments — averaging $219.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$4K
  • Histosonics, Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Siemens Medical Solutions USA, Inc.$961
  • Elekta, Inc.$820
  • Zap Surgical Systems, Inc.$246
  • plus $1K from 10 others

What the payments were for

  • Consulting fees$4,43343%
  • Speaking & faculty fees$5005%
  • Travel & lodging$1,19112%
  • Food & beverage$4,09240%
  • Education$1001%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,315 in reported general payments places this provider in the 90th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California →

Medicare billing

Part B allowed, 2024
$370,786
Medicare patients
257
Services billed
4,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl43$704
Lidocaine Hcl ViscousLidocaine Hcl18$682
Oxybutynin Chloride25$589
SsdSilver Sulfadiazine18$554
Dexamethasone15$538

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Eureka

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →